Clinique Générale-Beaulieu

Dr. med. Laure Thouvenin

Medical Oncology
General Internal Medicine

Languages
FR EN
Areas of specialisation (2)

Contact me

Hospital (1)

Générale-Beaulieu Swiss Oncology Network
Chemin de Beau-Soleil 20
1206 Genève

Education

since 2024

Participation in the certificate of advanced studies (CAS) "Integrative and complementary medicine in hospitals and the community"

2023

FMH title of specialist in internal medicine

2021

FMH title of specialist in medical oncology

2006 - 2012

Geneva University of Medicine, federal diploma in medicine

Memberships

  • European Society for Medical Oncology (ESMO)
  • Association Suisse des Médecins (FMH) (en cours)
  • Association des Médecins du canton de Genève (AMGe) (en cours)
  • Société Suisse d’Oncologie Médicale (SSOM) (en cours)

Work Experience

2021 - 2024

Senior consultant in the medical oncology department of the University Hospitals of Geneva (inpatient, outpatient)

2016 - 2021

Outpatient medical oncology (Geneva University Hospitals), including one year in clinical research (research unit of the Dr Henri Dubois-Ferrière Dinu Lipatti Foundation)

2012 - 2016

General internal medicine (Hôpital de la Tour, then University Hospitals of Geneva) (in-hospital, emergency, intensive care)

Publications

Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland. S Colomer-LahigueraC CanellaS GiacominiK Lê VanC PedrazzaniM NaegeleL ThouveninA O'Meara SternR CondorelliT CorbièreC Witt, M EicherK Ribi. Support Care Cancer. 2023 Jun 22;31(7):410. doi: 10.1007/s00520-023-07871-8.

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation : the prospective HEMOBREAST cohort. Blondon M, Bodmer A, Thouvenin L, Lecompte T, Righini M, Fontana P, Casini A.Blood Adv. 2022 May 10;6(9):2884-2892. doi: 10.1182/bloodadvances.2021006623

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab. Thouvenin L, Charrier M, Clement S, Christinat Y, Tille JC, Frigeri M, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P.Gynecol Oncol Rep. 2021 May 19;37:100787. doi: 10.1016/j.gore.2021.100787. eCollection 2021 Aug

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis : a case-series and narrative review. Thouvenin L, Olivier T, Banna G, Addeo A, Friedlaender A. Ther Adv Drug Saf. 2021 Mar 29;12:20420986211004745. doi: 10.1177/20420986211004745. eCollection 2021

A new hope in the treatment of hepatocellular carcinoma. Thouvenin L, Friedlaender A.Rev Med Suisse. 2020 May 27;16(695):1074-1078

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss. Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P.Cancer Biol Ther. 2020;21(3):197-202. doi: 10.1080/15384047.2019.1685291. Epub 2019 Nov 10

Monoclonal gammopathies: from MGUS to multiple myeloma. Thouvenin L, Lang N.Rev Med Suisse. 2019 May 15;15(651):1022-1026

Doctors with this specialisation

fallback-image
Clinique Générale-Beaulieu

Dr. med. Denis Dupont

Specialisation
Internal medicine
Clinique Générale-Beaulieu

Dr. med. Jeanne Berner

Specialisation
Internal medicine, Rheumatology
fallback-image
Clinique Générale-Beaulieu

Dr. med. France Laurencet

Specialisation
Oncology
Clinique Générale-Beaulieu

Dr. med. Till Saxer

Specialisation
Internal medicine
fallback-image
Clinique Générale-Beaulieu

Dr. med. Hamid Reza Sadagdar Ashkin

Specialisation
Internal medicine
fallback-image
Clinique Générale-Beaulieu

Dr. med. Didier Amblard

Specialisation
Internal medicine